These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8049700)

  • 1. Immunotherapy in pollen and mould asthma.
    Bonifazi F
    Monaldi Arch Chest Dis; 1994 Apr; 49(2):150-3. PubMed ID: 8049700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allergen-specific immune therapy in the treatment of asthma].
    Malling HJ
    Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection allergen immunotherapy for asthma.
    Abramson MJ; Puy RM; Weiner JM
    Cochrane Database Syst Rev; 2010 Aug; (8):CD001186. PubMed ID: 20687065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The progress on allergen-specific immunotherapy for bronchial asthma].
    Liu HY; Xie LY; Zhou LF
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):450-4. PubMed ID: 24103210
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunotherapy with an oral Alternaria extract in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters].
    Criado Molina A; Guerra Pasadas F; Daza Muñoz JC; Moreno Aguilar C; Almeda Llamas E; Muñoz Gomariz E; Font Ugalde P; Alonso Díaz C; Germán Cárdenas M; Sánchez Guijo P
    Allergol Immunopathol (Madr); 2002; 30(6):319-30. PubMed ID: 12464165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen.
    Park HS; Nahm DH; Kim HY; Suh YJ; Cho JW; Kim SS; Lee SK; Jung KS
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):444-8. PubMed ID: 11345290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
    Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
    Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen immunotherapy for asthma.
    Abramson MJ; Puy RM; Weiner JM
    Cochrane Database Syst Rev; 2003; (4):CD001186. PubMed ID: 14583928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy.
    Aberer W; Hawranek T; Reider N; Schuster C; Sturm G; Kränke B
    J Investig Allergol Clin Immunol; 2007; 17(3):131-6. PubMed ID: 17583098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immunotherapy in asthma.
    Bousquet J; Michel FB
    Allergy Proc; 1994; 15(6):329-33. PubMed ID: 7721083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
    Guerra F; Daza JC; Almeda E
    J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen immunotherapy for asthma.
    Abramson MJ; Puy RM; Weiner JM
    Cochrane Database Syst Rev; 2000; (2):CD001186. PubMed ID: 10796617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters.
    Lizaso MT; Tabar AI; García BE; Gómez B; Algorta J; Asturias JA; Martínez A
    Pediatr Allergy Immunol; 2008 Feb; 19(1):76-81. PubMed ID: 17662037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
    Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
    J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.